Gabapentin may be appropriate for off-label uses.
Davis
Shawn
S
D000085:Acetates / Q000191:economics / Q000627:therapeutic use*; D000588:Amines; D000927:Anticonvulsants / Q000191:economics / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids; D017277:Drug Approval; D004348:Drug Labeling; D019317:Evidence-Based Medicine; D000077206:Gabapentin; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin